{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:40:24Z","timestamp":1792438824038,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371358"],"award-info":[{"award-number":["82371358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2025ZD0546002"],"award-info":[{"award-number":["2025ZD0546002"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","award":["2023BEG02073"],"award-info":[{"award-number":["2023BEG02073"]}],"id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00769","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T03:11:35Z","timestamp":1762571495000},"page":"e00769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Salidroside ameliorates experimental autoimmune neuritis by dually modulating neuroinflammation and immune homeostasis via PI3K\/AKT signaling"],"prefix":"10.1016","volume":"23","author":[{"given":"Tao","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2025.e00769_bib1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2025.e00769_bib2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","article-title":"Infectious and noninfectious triggers in Guillain-Barr\u00e9 syndrome","volume":"9","author":"Wakerley","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.neurot.2025.e00769_bib3","doi-asserted-by":"crossref","first-page":"577042","DOI":"10.1016\/j.jneuroim.2019.577042","article-title":"Intravenous immunoglobulin promotes the proliferation of CD4+CD25+ Foxp3+ regulatory T cells and the cytokines secretion in patients with Guillain-Barr\u00e9 syndrome in vitro","volume":"336","author":"Zhang","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurot.2025.e00769_bib4","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"2019","author":"Mahdi-Rogers","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurot.2025.e00769_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1478","article-title":"Th17 cells and their cytokines serve as potential therapeutic target in experimental autoimmune neuritis","volume":"9","author":"Liu","year":"2019","journal-title":"Brain Behav"},{"key":"10.1016\/j.neurot.2025.e00769_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","article-title":"Th17 cells and IL-17 a--focus on immunopathogenesis and immunotherapeutics","volume":"43","author":"van den Berg","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.neurot.2025.e00769_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/758639","article-title":"Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Nyati","year":"2014","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.neurot.2025.e00769_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/14728222.2018.1484109","article-title":"Roles of macrophage migration inhibitory factor in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis: beneficial or harmful?","volume":"22","author":"Shen","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.neurot.2025.e00769_bib9","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.intimp.2019.02.050","article-title":"M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds","volume":"70","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2025.e00769_bib10","doi-asserted-by":"crossref","first-page":"109552","DOI":"10.1016\/j.biopha.2019.109552","article-title":"Anti-inflammatory effects of Rhodiola rosea L.: a review","volume":"121","author":"Pu","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neurot.2025.e00769_bib11","doi-asserted-by":"crossref","first-page":"172797","DOI":"10.1016\/j.ejphar.2019.172797","article-title":"Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK\/NF-\u03baB\/NLRP3 signaling pathway in AGEs-induced HUVECs","volume":"867","author":"Hu","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00769_bib12","doi-asserted-by":"crossref","first-page":"109268","DOI":"10.1016\/j.cbi.2020.109268","article-title":"Salidroside: a review of its recent advances in synthetic pathways and pharmacological properties","volume":"339","author":"Zhang","year":"2021","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.neurot.2025.e00769_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phymed.2010.02.002","article-title":"Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy","volume":"17","author":"Panossian","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neurot.2025.e00769_bib14","article-title":"Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation","author":"Wang","year":"2017","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.neurot.2025.e00769_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12964-022-00994-1","article-title":"Salidroside attenuates HALI via IL-17A-mediated ferroptosis of alveolar epithelial cells by regulating Act1-TRAF6-p38 MAPK pathway","volume":"20","author":"Guo","year":"2022","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.neurot.2025.e00769_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain-Barr\u00e9 syndrome: epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.neurot.2025.e00769_bib17","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2020.01603","article-title":"M1 macrophage derived exosomes aggravate experimental autoimmune neuritis via modulating Th1 response","volume":"11","author":"Du","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2025.e00769_bib18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/cei.13637","article-title":"Nuclear factor kappa B inhibitor suppresses experimental autoimmune neuritis in mice via declining macrophages polarization to M1 type","volume":"206","author":"Shen","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.neurot.2025.e00769_bib19","article-title":"Pathogenic TNF-\u03b1 drives peripheral nerve inflammation in an aire-deficient model of autoimmunity","volume":"119","author":"Wang","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2025.e00769_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ilar\/ilt054","article-title":"Animal models of autoimmune neuropathy","volume":"54","author":"Soliven","year":"2014","journal-title":"ILAR J"},{"key":"10.1016\/j.neurot.2025.e00769_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurot.2025.e00769_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jnci\/djj133","article-title":"Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor","volume":"98","author":"Yaguchi","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.neurot.2025.e00769_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00011-012-0444-8","article-title":"Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats","volume":"61","author":"Haruta","year":"2012","journal-title":"Inflamm Res"},{"key":"10.1016\/j.neurot.2025.e00769_bib24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00109-014-1158-x","article-title":"ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis","volume":"92","author":"Xue","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"Suppl 4","key":"10.1016\/j.neurot.2025.e00769_bib25","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"10.1016\/j.neurot.2025.e00769_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellimm.2018.04.011","article-title":"Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1\/Th17 cells and reducing the production of proinflammatory cytokines","volume":"329","author":"Chen","year":"2018","journal-title":"Cell Immunol"},{"issue":"Pt 7","key":"10.1016\/j.neurot.2025.e00769_bib27","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/brain\/121.7.1257","article-title":"The role of the very late antigen-4 and its counterligand vascular cell adhesion molecule-1 in the pathogenesis of experimental autoimmune neuritis of the lewis rat","volume":"121","author":"Enders","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2025.e00769_bib28","doi-asserted-by":"crossref","first-page":"577470","DOI":"10.1016\/j.jneuroim.2020.577470","article-title":"Nerve conductions studies in experimental models of autoimmune neuritis: a meta-analysis and guideline","volume":"352","author":"Kohle","year":"2021","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurot.2025.e00769_bib29","doi-asserted-by":"crossref","first-page":"112915","DOI":"10.1016\/j.intimp.2024.112915","article-title":"Erianin alleviates cerebral ischemia-reperfusion injury by inhibiting microglial cell polarization and inflammation via the PI3K\/AKT and NF-\u03baB pathways","volume":"141","author":"Jia","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2025.e00769_bib30","doi-asserted-by":"crossref","first-page":"176236","DOI":"10.1016\/j.ejphar.2023.176236","article-title":"Salidroside attenuates myocardial remodeling in DOCA-salt-induced mice by inhibiting the endothelin 1 and PI3K\/AKT\/NF\u03baB signaling pathways","volume":"962","author":"Liu","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00769_bib31","doi-asserted-by":"crossref","first-page":"117470","DOI":"10.1016\/j.lfs.2020.117470","article-title":"Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K\/AKT and NF-\u03baB signaling pathways","volume":"249","author":"Rahmani","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.neurot.2025.e00769_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10787-022-01098-5","article-title":"Maltol ameliorates intervertebral disc degeneration through inhibiting PI3K\/AKT\/NF-\u03baB pathway and regulating NLRP3 inflammasome-mediated pyroptosis","volume":"31","author":"Gong","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neurot.2025.e00769_bib33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12967-022-03337-3","article-title":"Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4\/NF-kB signaling pathway","volume":"20","author":"Wu","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.neurot.2025.e00769_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10616-025-00751-5","article-title":"Correction: proanthocyanidin B2 alleviates Pg.LPS-induced RAW264.7 cellular inflammation and oxidative stress via PI3K\/Akt\/NFkB pathway","volume":"77","author":"Chen","year":"2025","journal-title":"Cytotechnology"},{"key":"10.1016\/j.neurot.2025.e00769_bib35","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2174\/1389557520666200204121129","article-title":"Consensus analyses in molecular docking studies applied to medicinal chemistry","volume":"20","author":"Dos Santos Maia","year":"2020","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.neurot.2025.e00769_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s12906-022-03753-4","article-title":"Network toxicology and molecular docking analyses on strychnine indicate CHRM1 is a potential neurotoxic target","volume":"22","author":"Dai","year":"2022","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.neurot.2025.e00769_bib37","doi-asserted-by":"crossref","first-page":"114429","DOI":"10.1016\/j.intimp.2025.114429","article-title":"TAK-242 attenuates NLRP3-ASC inflammasome-mediated neuroinflammation via TLR4\/NF-\u03baB pathway in rat experimental autoimmune neuritis","volume":"153","author":"Li","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.neurot.2025.e00769_bib38","doi-asserted-by":"crossref","first-page":"1134429","DOI":"10.3389\/fphar.2023.1134429","article-title":"Cordyceps militaris extracts and cordycepin ameliorate type 2 diabetes mellitus by modulating the gut microbiota and metabolites","volume":"14","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00769_bib39","article-title":"Salidroside ameliorates severe acute pancreatitis-induced cell injury and pyroptosis by inactivating Akt\/NF-\u03baB and caspase-3\/GSDME pathways","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:08:00Z","timestamp":1774858080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002478"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00769","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salidroside ameliorates experimental autoimmune neuritis by dually modulating neuroinflammation and immune homeostasis via PI3K\/AKT signaling","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00769"}}